These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 9630978)
1. Immunopotency of a viral peptide assembled on the carbohydrate moieties of self immunoglobulins. Brumeanu TD; Casares S; Harris PE; Dehazya P; Wolf I; von Boehmer H; Bona CA Nat Biotechnol; 1996 Jun; 14(6):722-5. PubMed ID: 9630978 [TBL] [Abstract][Full Text] [Related]
2. Presentation of a viral peptide assembled on the carbohydrate moieties of immunoglobulin does not require processing. Brumeanu TD; Casares S; Dehazya P; Bot S; Bona CA Eur J Immunol; 1997 Sep; 27(9):2408-16. PubMed ID: 9341787 [TBL] [Abstract][Full Text] [Related]
3. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer. Bristol JA; Schlom J; Abrams SI Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883 [TBL] [Abstract][Full Text] [Related]
4. Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization. Bristol JA; Orsini C; Lindinger P; Thalhamer J; Abrams SI Cell Immunol; 2000 Nov; 205(2):73-83. PubMed ID: 11104579 [TBL] [Abstract][Full Text] [Related]
6. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40. Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104 [TBL] [Abstract][Full Text] [Related]
7. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells. May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141 [TBL] [Abstract][Full Text] [Related]
8. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa. Dobaño C; Doolan DL Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242 [TBL] [Abstract][Full Text] [Related]
9. Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II--peptide chimera. Casares S; Stan AC; Bona CA; Brumeanu TD Nat Biotechnol; 2001 Feb; 19(2):142-7. PubMed ID: 11175728 [TBL] [Abstract][Full Text] [Related]
10. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes. Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515 [TBL] [Abstract][Full Text] [Related]
11. Engineering of doubly antigenized immunoglobulins expressing T and B viral epitopes. Brumeanu TD; Bot A; Bona CA; Dehazya P; Wolf I; Zaghouani H Immunotechnology; 1996 Jun; 2(2):85-95. PubMed ID: 9373317 [TBL] [Abstract][Full Text] [Related]
12. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors. Marzo AL; Lake RA; Robinson BW; Scott B Cancer Res; 1999 Mar; 59(5):1071-9. PubMed ID: 10070965 [TBL] [Abstract][Full Text] [Related]
13. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes. Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194 [TBL] [Abstract][Full Text] [Related]
14. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory. Hao S; Yuan J; Xiang J J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150 [TBL] [Abstract][Full Text] [Related]
15. Evaluating strategies to enhance the anti-tumor immune response to a carbohydrate mimetic peptide vaccine. Monzavi-Karbassi B; Pashov A; Jousheghany F; Artaud C; Kieber-Emmons T Int J Mol Med; 2006 Jun; 17(6):1045-52. PubMed ID: 16685414 [TBL] [Abstract][Full Text] [Related]
16. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells. Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772 [TBL] [Abstract][Full Text] [Related]
18. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells. Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients. Mancini-Bourgine M; Bayard F; Soussan P; Deng Q; Lone YC; Kremsdorf D; Michel ML J Virol; 2007 May; 81(10):4963-72. PubMed ID: 17360751 [TBL] [Abstract][Full Text] [Related]
20. Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma. Wong R; Lau R; Chang J; Kuus-Reichel T; Brichard V; Bruck C; Weber J Clin Cancer Res; 2004 Aug; 10(15):5004-13. PubMed ID: 15297401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]